Research Paper | Pharmacology and Toxicology | India | Volume 11 Issue 4, April 2022
A Review of Triple-Negative Breast Cancer and Systemic Treatment
Abstract: Triple-negative breast cancer (TNBC) is a heterogeneous disease that does not express the estrogen/progesterone-receptor (ER/PR), and human epidermal growth factor receptor-2 (HER2). TNBC is characterized as more aggressive and less responsive to standard treatment and associated with overall poorer prognosis. Chemotherapy is the choice of systemic therapy for triple-negative tumors. This review describes the most recent data on targeted therapies that have demonstrated efficacy in the management of TNBC. The monotherapy will be efficacious in all patients with TNBC. The most effective treatment approach for these patients is likely to be a combination of targeted therapies with cytotoxic agents. Identification of molecular targets and tailored treatments based on the molecular alterations in individual cancers hold the best promise for improving the outcomes of this aggressive breast cancer.
Keywords: Triple Negative Breast Cancer, BRCA Mutations, Targeted Therapies
Edition: Volume 11 Issue 4, April 2022,
Pages: 69 - 71
How to Cite this Article?
Venkataramana Inagaluri, "A Review of Triple-Negative Breast Cancer and Systemic Treatment", International Journal of Science and Research (IJSR), https://www.ijsr.net/get_abstract.php?paper_id=SR22329143515, Volume 11 Issue 4, April 2022, 69 - 71, #ijsrnet
How to Share this Article?
Similar Articles with Keyword 'Breast'
Study the Total Flavonoid, Reductive Ability and Cytotoxic Effects of Lantanacamaraethanolic Extract on Prostate and Breast Cancer Cell Line
Rafal S. A. Al-Anee
A Review Literature on Science of Breast Cancer
Neda Fatima | Shweta Singh